Sarepta Therapeutics | SRPT - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Capricor Therapeutics USD 1.66B 1.33B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
Incyte USD 18.73B 660M 2026-03
Insmed USD 35.3B 1.82B 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novavax USD 1.09B 316M 2025-12
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Tectonic Therapeutic USD 510M 70M 2026-07
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03